AR011160A1 - Uso de acido graso poliinsaturado, de fosfolipidos, colina para preparar medicamentos utiles para reducir la incidencia de la enterocolitis necrosante,para la produccion de una formulacion enteral y formulacion enteral mejorada - Google Patents
Uso de acido graso poliinsaturado, de fosfolipidos, colina para preparar medicamentos utiles para reducir la incidencia de la enterocolitis necrosante,para la produccion de una formulacion enteral y formulacion enteral mejoradaInfo
- Publication number
- AR011160A1 AR011160A1 ARP980100780A ARP980100780A AR011160A1 AR 011160 A1 AR011160 A1 AR 011160A1 AR P980100780 A ARP980100780 A AR P980100780A AR P980100780 A ARP980100780 A AR P980100780A AR 011160 A1 AR011160 A1 AR 011160A1
- Authority
- AR
- Argentina
- Prior art keywords
- incidence
- phospholipids
- choline
- enteral formulation
- fatty acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80470097A | 1997-02-21 | 1997-02-21 | |
| US82531497A | 1997-03-28 | 1997-03-28 | |
| US08/943,576 US6080787A (en) | 1997-02-21 | 1997-10-03 | Methods for reducing the incidence of necrotizing enterocolitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011160A1 true AR011160A1 (es) | 2000-08-02 |
Family
ID=27122714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980100780A AR011160A1 (es) | 1997-02-21 | 1998-02-20 | Uso de acido graso poliinsaturado, de fosfolipidos, colina para preparar medicamentos utiles para reducir la incidencia de la enterocolitis necrosante,para la produccion de una formulacion enteral y formulacion enteral mejorada |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6080787A (cg-RX-API-DMAC7.html) |
| JP (1) | JP2011137015A (cg-RX-API-DMAC7.html) |
| KR (1) | KR100439166B1 (cg-RX-API-DMAC7.html) |
| AR (1) | AR011160A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL150490A (cg-RX-API-DMAC7.html) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22723A1 (es) * | 1997-04-02 | 2002-02-28 | Dalmer Lab Sa | Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos |
| EP1090636A1 (en) * | 1999-09-13 | 2001-04-11 | Société des Produits Nestlé S.A. | High lipid diet |
| EP1181870A1 (en) * | 2000-08-22 | 2002-02-27 | Belovo Eggs & Egg Products | Manufactured lipid emulsion having an improved balanced dietary source of vitamin F |
| EP1372641A4 (en) * | 2001-03-05 | 2004-08-25 | Stephen P Ernest | ENTERAL FORMULATION |
| US6620427B2 (en) * | 2001-04-24 | 2003-09-16 | Abbott Laboratories | Method for improving bone mineralization |
| EP1392278A4 (en) * | 2001-05-14 | 2005-05-04 | Martek Biosciences Corp | PREPARATION AND USE OF A POLAR LIPIDREICH FRACTION WITH STEARIDONIC ACID AND GAMMA LINOLIC ACID FROM PLANT SEEDS AND MICROBES |
| EP1392623A4 (en) * | 2001-05-14 | 2005-05-04 | Martek Biosciences Corp | PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS |
| JP2003048831A (ja) * | 2001-08-02 | 2003-02-21 | Suntory Ltd | 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| US20040013787A1 (en) * | 2002-06-28 | 2004-01-22 | Theuer Richard C. | Fat compositions for infant formula and methods therefor |
| KR101195574B1 (ko) * | 2002-09-24 | 2012-10-30 | 산토리 홀딩스 가부시키가이샤 | 아라키돈산을 단독으로 또는 도코사헥사엔산과의 조합으로함유하는 인지 능력 향상용 조성물 |
| DK1589834T3 (da) * | 2003-02-05 | 2007-06-18 | Nutricia Nv | Enteral komposition til forebyggelse og/eller behandling af sepsis |
| GB0311081D0 (en) * | 2003-05-14 | 2003-06-18 | Btg Internat Limted | Treatment of neurodegenerative conditions |
| KR20060030860A (ko) * | 2003-06-24 | 2006-04-11 | 유니버시티 오브 캔사스 메디컬 센터 | 유아 조제유 |
| EP2324828A1 (en) * | 2003-08-18 | 2011-05-25 | BTG International Limited | Treatment for neurodegenerative conditions |
| JP4522075B2 (ja) * | 2003-10-29 | 2010-08-11 | サントリーホールディングス株式会社 | 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP4993852B2 (ja) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | ストレスに起因する行動異常を伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| JP2006083136A (ja) * | 2004-09-17 | 2006-03-30 | Suntory Ltd | ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物 |
| GB0425932D0 (en) * | 2004-11-25 | 2004-12-29 | Btg Int Ltd | Structured phospholipids |
| GB0504333D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Treatment of cytokine dysregulation |
| GB0504362D0 (en) * | 2005-03-02 | 2005-04-06 | Btg Int Ltd | Cytokine modulators |
| CA2645645C (en) * | 2005-05-23 | 2015-07-14 | Massachusetts Institute Of Technology | Compositions containing pufa and methods of use thereof |
| JP5697293B2 (ja) * | 2005-06-30 | 2015-04-08 | サントリーホールディングス株式会社 | 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物 |
| JP5967855B2 (ja) * | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | 日中活動量の低下および/又はうつ症状の改善作用を有する組成物 |
| US7829126B2 (en) | 2005-10-26 | 2010-11-09 | Abbott Laboratories | Infant formulas containing docosahexaenoic acid and lutein |
| US20070166354A1 (en) * | 2005-10-26 | 2007-07-19 | Bridget Barrett-Reis | Method of reducing the risk of retinopathy of prematurity in preterm infants |
| KR101578498B1 (ko) * | 2006-12-28 | 2015-12-18 | 산토리 홀딩스 가부시키가이샤 | 신경 재생제 |
| WO2008147562A2 (en) * | 2007-05-25 | 2008-12-04 | Childrens's Medical Center Corporation | Dietary formulations and methods for treatment of inflammation and other disorders |
| CN101801200B (zh) * | 2007-09-17 | 2014-10-29 | 康奈尔大学 | 用于预防或治疗胃肠病症的支链脂肪酸 |
| EP2258216A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
| US20110200645A1 (en) * | 2010-02-18 | 2011-08-18 | Martek Biosciences Corporation | DHA Free Fatty Acid Emulsions |
| US20110206741A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | DHA Triglyceride Emulsions |
| WO2011103510A1 (en) * | 2010-02-18 | 2011-08-25 | Martek Biosciences Corporation | Dha ester emulsions |
| EP3338784B1 (en) | 2010-12-31 | 2020-07-22 | Abbott Laboratories | Human milk oligosaccharides for modulating inflammation |
| MX388089B (es) | 2010-12-31 | 2025-03-19 | Abbott Lab | Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas. |
| EP2658400A2 (en) | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof |
| DK2658399T4 (da) | 2010-12-31 | 2024-03-25 | Abbott Lab | Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion |
| NZ611807A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
| BR112013016929A2 (pt) | 2010-12-31 | 2019-09-24 | Abbott Lab | oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas |
| ES2804258T3 (es) | 2010-12-31 | 2021-02-05 | Abbott Lab | Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios |
| DK2734210T3 (en) | 2011-07-22 | 2018-01-22 | Abbott Lab | GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL |
| US10639319B2 (en) | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| WO2014078544A1 (en) * | 2012-11-14 | 2014-05-22 | Abbott Laboratories | Compositions and methods for improving the long term safety of powdered infant formulas |
| MX2015007935A (es) | 2012-12-18 | 2015-10-09 | Abbott Lab | Fortificador de leche humana liquido concentrado que contiene proteina hipoalergenica y luteina. |
| WO2017117121A1 (en) * | 2015-12-28 | 2017-07-06 | Abbott Laboratories | Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3374914D1 (en) * | 1982-04-12 | 1988-01-28 | Univ Texas | Methods and compositions for treating gastro-intestinal ulcer diesease |
| US4670285A (en) * | 1982-08-06 | 1987-06-02 | The University Of Toronto Innovations Foundation | Infant formula |
| US4784861A (en) * | 1986-11-24 | 1988-11-15 | Cca Industries, Inc. | Weight-control formulation |
| US4918063A (en) * | 1987-02-17 | 1990-04-17 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
| US5032585A (en) * | 1987-02-17 | 1991-07-16 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy |
| US4950656A (en) * | 1987-02-17 | 1990-08-21 | Board Of Regents, The University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
| US5043329A (en) * | 1987-02-17 | 1991-08-27 | Board Of Regents, University Of Texas System | Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract |
| DE3734147C2 (de) * | 1987-10-09 | 1998-10-29 | Braun Melsungen Ag | Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung |
| US5000975A (en) * | 1988-12-29 | 1991-03-19 | American Home Products Corporation | Randomized palm oil fat composition for infant formulas |
| US5658767A (en) * | 1991-01-24 | 1997-08-19 | Martek Corporation | Arachidonic acid and methods for the production and use thereof |
| WO1992012711A1 (en) * | 1991-01-24 | 1992-08-06 | Martek Corporation | Microbial oil mixtures and uses thereof |
| WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
| FR2721481B1 (fr) * | 1994-06-27 | 1996-09-06 | Inst Rech Biolog Sa | Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel. |
| DK0784437T3 (da) * | 1994-10-05 | 1999-04-19 | Milupa Gmbh & Co Kg | Phospholipidholdig fedtblanding med LCP-fedtsyrer |
| JPH09201A (ja) * | 1995-06-23 | 1997-01-07 | Akikuni Yakida | 炎症性腸疾患用食品 |
| US5917068A (en) * | 1995-12-29 | 1999-06-29 | Eastman Chemical Company | Polyunsaturated fatty acid and fatty acid ester mixtures free of sterols and phosphorus compounds |
| US6200624B1 (en) * | 1996-01-26 | 2001-03-13 | Abbott Laboratories | Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids |
-
1997
- 1997-10-03 US US08/943,576 patent/US6080787A/en not_active Expired - Lifetime
-
1998
- 1998-02-19 KR KR10-1999-7007598A patent/KR100439166B1/ko not_active Expired - Fee Related
- 1998-02-20 AR ARP980100780A patent/AR011160A1/es unknown
-
2002
- 2002-06-30 IL IL150490A patent/IL150490A/en not_active IP Right Cessation
-
2011
- 2011-02-10 JP JP2011027692A patent/JP2011137015A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR100439166B1 (ko) | 2004-07-07 |
| US6080787A (en) | 2000-06-27 |
| JP2011137015A (ja) | 2011-07-14 |
| IL150490A (en) | 2007-05-15 |
| KR20000075539A (ko) | 2000-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR005556A1 (es) | Formula enteral, un suplemento nutricional que contiene una composicion de trigliceridos, trigliceridos, y un procedimiento para preparar esteres de acidos grasos a partir de una mezcla de lipidos | |
| CA1324155C (en) | Dietary supplement utilizing omega-3/medium chain triglyceride mixtures | |
| BR9807443A (pt) | Processos para reduzir a incidência de enterocolite necrótica em uma criança e para a produção de uma fórmula enteral, e, fórmulas enteral aperfeiçoada contendo ácido araquidÈnico e ácido docosaexaenóico e adequada para alimentar crianças. | |
| US4407821A (en) | Lipidic compositions for use in dietetics, reanimation and therapeutics | |
| CL2009000799A1 (es) | Composicion de alimento materno que comprende una fuente de lipidos donde los lipidos incluyen al menos un acido graso poliinsaturado de cadena larga seleccionado de: fosfolipidos, fosfatidilcolina, fosfatidiletanolamina, n-acilfosfatidiletanolamina, fosfatidilinositol, fosfatidilserina y/o sus liso derivados; usos. | |
| KR940018091A (ko) | 불포화 지방산을 포함하는 처방 | |
| RU99119892A (ru) | Способы и составы для снижения заболеваемости некротическим энтероколитом (варианты), способ получения состава | |
| RU2005120159A (ru) | Водорастворимые концентраты эмульсионного типа | |
| IT9021610A1 (it) | Composizioni per il trattamento della pelle contenenti derivati della b-fosfatidilcolina | |
| US6251425B1 (en) | Glucoside paucilamellar vesicles | |
| Che et al. | Long-term effects of docosahexaenoic acid-bound phospholipids and the combination of docosahexaenoic acid-bound triglyceride and egg yolk phospholipid on lipid metabolism in mice | |
| JP2004505904A (ja) | 化粧品において脂質成分として使用する皮脂用調整物 | |
| CA2207325A1 (en) | Anti-oxidant compositions | |
| DE59803855D1 (de) | Hautpflegemittel | |
| JP3081226B2 (ja) | 脂肪又は脂肪含有製品の酸化防止方法 | |
| Galli et al. | Modulation of lipid derived mediators by polyunsaturated fatty acids | |
| EP0409559A2 (en) | Pharmaceutical uses of fatty acids | |
| Señoráns et al. | Formulations based on milk fat globule membrane as delivery systems for DHA and lutein: effects on lipid composition and immunomodulatory properties | |
| Noble et al. | The liver phospholipids of the developing chick embryo | |
| JPH07503014A (ja) | 癌の治療におけるカロチノイド類の処方及び用法 | |
| Jannace et al. | Effects of oral soy phosphatidylcholine on phagocytosis, arachidonate concentrations, and killing by human polymorphonuclear leukocytes | |
| JP2514995B2 (ja) | 経皮、経粘膜による物質の吸収を促進する組成物 | |
| Ishinaga et al. | Perturbation of phospholipid metabolism by erucic acid in male Sprague-Dawley rat heart | |
| Lewis | Lipid composition of human bronchial mucus | |
| Alam et al. | Excessive intake of 13-cis retinoic acid and fatty acid composition of tissues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |